Sunshine Biopharma (SBFM) Stock Chart & Stock Price History $1.51 -0.01 (-0.66%) Closing price 04:00 PM EasternExtended Trading$1.52 +0.01 (+0.66%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sunshine Biopharma Stock Price Performance The Sunshine Biopharma (SBFM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 407.05%, with a year-to-date return of -49.67%. In the past month, the stock has increased 3.07%, reflecting recent market activity. As of the latest close, Sunshine Biopharma traded at $1.52 with a market cap of $6.93 million and volume of 54,784 shares. Receive SBFM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.58%1 Month Performance+3.07%3 Month Performance+8.63%Year-To-Date Performance-49.67%1 Year Performance+407.05% SBFM Stock Chart for Tuesday, July, 29, 2025 SBFM Chart by TradingView Sunshine Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/29/2025$1.52$1.51-0.66%$1.56$1.4854,713 shs$6.89 million07/28/2025$1.56$1.52-2.56%$1.57$1.5154,784 shs$6.93 million07/25/2025$1.55$1.56+0.65%$1.57$1.5070,701 shs$7.11 million07/24/2025$1.58$1.55-1.90%$1.59$1.5464,576 shs$7.07 million07/23/2025$1.59$1.58-0.63%$1.60$1.51120,891 shs$7.20 million07/22/2025$1.56$1.59+1.92%$1.60$1.5446,791 shs$7.25 million07/21/2025$1.56$1.56$1.61$1.5459,685 shs$7.11 million07/18/2025$1.60$1.56-2.50%$1.60$1.5472,307 shs$7.11 million07/17/2025$1.52$1.60+5.26%$1.60$1.5398,948 shs$7.29 million07/16/2025$1.51$1.52+0.80%$1.53$1.4744,611 shs$6.93 million Get the Latest News and Ratings for SBFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. 07/15/2025$1.49$1.51+1.21%$1.56$1.42150,502 shs$6.87 million07/14/2025$1.54$1.49-3.25%$1.54$1.45169,283 shs$6.79 million07/11/2025$1.60$1.54-3.45%$1.59$1.5079,999 shs$7.02 million07/10/2025$1.56$1.60+2.24%$1.61$1.5674,803 shs$7.27 million07/09/2025$1.52$1.56+2.63%$1.61$1.48115,451 shs$7.11 million07/08/2025$1.47$1.52+3.40%$1.53$1.4378,429 shs$6.93 million07/07/2025$1.54$1.47-4.23%$1.56$1.44161,835 shs$6.70 million07/04/2025$1.54$1.54$1.65$1.53292,844 shs$6.99 million07/03/2025$1.65$1.54-6.97%$1.65$1.53292,844 shs$7 million07/02/2025$1.45$1.65+13.79%$1.75$1.422.05 million shs$7.52 million07/01/2025$1.44$1.45+0.69%$1.49$1.4325,401 shs$6.61 million06/30/2025$1.47$1.44-1.71%$1.46$1.4241,979 shs$6.57 million Related Companies SCYX Stock Chart ENLV Stock Chart NRSN Stock Chart GBIO Stock Chart NNVC Stock Chart ALXO Stock Chart QTTB Stock Chart FBLG Stock Chart CLSD Stock Chart RANI Stock Chart Receive SBFM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SBFM) was last updated on 7/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
